Position in ATEC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$91,023
+$28,061 QoQ
Shares Held
10,523
+81.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#212
of 265 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATEC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MAI Capital Management holds $114,360,678 across 14 Medical Devices names. ATEC ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
437,641 | $39,711,543 | |
| 2 | SYK |
Stryker Corp
|
114,533 | $36,059,569 | |
| 3 | BSX |
Boston Scientific Corp
|
519,011 | $22,151,389 | |
| 4 | MDT |
Medtronic plc
|
128,741 | $10,071,407 | |
| 5 | EW |
Edwards Lifesciences Corp
|
26,116 | $2,362,452 | |
| 6 | STE |
STERIS plc
|
4,786 | $1,007,787 | |
| 7 | PODD |
Insulet Corp
|
5,524 | $841,028 | |
| 8 | DXCM |
Dexcom Inc
|
9,049 | $609,450 |
All Filings in ATEC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,023 | 10,523 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $62,962 | 5,787 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,978 | 2,518 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,350 | 2,500 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $27,750 | 2,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,350 | 2,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,950 | 2,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||